2 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Terminated 1 |
Follow CILO: new trials by email Literature Review of CILO trials Research Report on CILO
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis Cilofexor - Primary Sclerosing Cholangitis, Compensated Cirrhosis | Phase 1 | Terminated | Gilead Sciences | 11 | 2019-10-17 | 2023-07-27 |
| Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) SEL, FIR, CILO - Nonalcoholic Steatohepatitis | Phase 2 | Completed | Gilead Sciences | 395 | 2018-03-21 | 2020-12-03 |
| Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) SEL, FIR, CILO - Nonalcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2 | Completed | Gilead Sciences | 220 | 2016-06-13 | 2022-03-16 |
Non-alcoholic Fatty Liver Disease (2) · Cholangitis, Sclerosing (1)
Gilead Sciences (3)
United States (3) · New Zealand (2) · Australia (1) · Canada (1) · Hong Kong (1) · Puerto Rico (1)